Primary Breast Diffuse Large B Cell Lymphoma: Summarization of 12 Cases / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 452-456, 2016.
Article
en Zh
| WPRIM
| ID: wpr-360068
Biblioteca responsable:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the clinicopathological manifestation, immunophenotypic features and prognostic factors of patients with primary breast DLBCL (PB-DLBCL).</p><p><b>METHODS</b>Twelve cases of PB-DLBCL, diagnosed according to the 2008 World Health Organization classification of tumors of hematopoietic and lymphoid tissues, were retrospectively studied.</p><p><b>RESULTS</b>Most patients were admitted to hospital because of painless unilateral breast mass. Out of 12 cases, 5 were in Ann Arbor stage I (41.7%), 7 case were in stage II (58.3%). Most (89.9%) were assigned to non-GCB subtypes, 11.1% were classified as GCB subtype. The patients who recepted treatment were sensitive to chemotherapy and they were all alive following 12 to 92 months.</p><p><b>CONCLUSION</b>Primary breast DLBCL is extremely rare without specific clinical features. They all respond well to chemotherapy and show good prognosis.</p>
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Patología
/
Pronóstico
/
Terapéutica
/
Neoplasias de la Mama
/
Tasa de Supervivencia
/
Estudios Retrospectivos
/
Linfoma de Células B Grandes Difuso
/
Diagnóstico
/
Estadificación de Neoplasias
Tipo de estudio:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
Límite:
Humans
Idioma:
Zh
Revista:
Journal of Experimental Hematology
Año:
2016
Tipo del documento:
Article